All In Biotech

Drug Trial Radar · NCT01370356

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

A Phase 4, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Last checked: Nov 19, 2026Latest source record: Sep 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,510 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,510

Actual

Start

Jul 2011

Primary completion

Jul 2013

Study completion Jul 2013

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jun 9, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Health services research
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will determine whether varenicline is safe and helps people to quit smoking through reduction when they are not willing/able to make an abrupt quit attempt.

Conditions

  • Smoking Cessation

Interventions

  • Varenicline TartrateDrug

    Varenicline Tartrate oral tablets 2 (0.5mg) tablets twice a day for 24 weeks (first week titration)

  • PlaceboDrug

    Matching placebo 2 oral tablets twice a day for 24 weeks (first week titration)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Carbon Monoxide (CO) Confirmed 10-Week Continuous Abstinence (CA) From SmokingTime frame: Week 15 - 24

Locations

65 sites in 10 countries. Site status is shown where the registry gives one.

  • Pharmacology Research Institute

    Encino, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Central Kentucky Research Associates, Inc.

    Lexington, Kentucky

  • Mayo Clinic

    Rochester, Minnesota

  • The Center for Pharmaceutical Research, P.C.

    Kansas City, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • CRI Worldwide, LLC

    Marlton, New Jersey

  • Clinical Research Integrity(CRI) Worldwide, LLC

    Willingboro, New Jersey

  • Central New York Clinical Research

    Manlius, New York

  • FutureSearch Clinical Trials, L.P.

    Austin, Texas

  • Benchmark Research

    Fort Worth, Texas

  • Healthfirst Medical Group

    Fort Worth, Texas

  • Australian Clinical Research Network

    Maroubra, New South Wales, Australia

  • Brisbane South Clinical Research Centre

    Carina Heights, Queensland, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia

  • Emeritus Research

    Malvern, Victoria, Australia

  • Office of Dr. Ronald Collette

    Burnaby, British Columbia, Canada

  • James K. Lai, MD., Inc.

    Vancouver, British Columbia, Canada

  • White Hills Medical Clinic

    St. John's, Newfoundland and Labrador, Canada

  • Canadian Phase Onward Inc.

    Toronto, Ontario, Canada

  • Manna Research

    Toronto, Ontario, Canada

  • Clinique des Maladies Lipidiques de Quebec (CMLQ)

    Québec, Quebec, Canada

  • SurGal Clinic s.r.o.

    Brno, Czechia

  • Fakultni nemocnice u sv. Anny v Brne

    Brno, Czechia

  • Krajska nemocnice Liberec a.s., Plicni oddeleni

    Liberec, Czechia

  • Mestska nemocnice Ostrava, Plicni oddeleni

    Ostrava, Czechia

  • Vseobecna fakultni nemocnice v Praze, III. interni klinika

    Prague, Czechia

  • Vseobecna fakultni nemocnice v Praze

    Prague, Czechia

  • Ustredni vojenska nemocnice Praha

    Prague, Czechia

  • Alexandria University

    Alexandria, Egypt

  • Ain Shams University Hospital

    Cairo, Egypt

  • El Fayoum university hospital

    El Fayoum Qesm, Egypt

  • Klinische Forschung Berlin

    Berlin, Germany

  • Klinische Forschung Berlin-Buch GmbH

    Berlin, Germany

  • Universitaetsklinikum Goettingen Zentrum Innere Medizin Abteilung Kardiologie und Pneumologie

    Göttingen, Germany

  • Universitaetsklinikum Goettingen, Zentrum Innere Medizin, Abteilung Kardiologie und Pneumologie

    Göttingen, Germany

  • Klinische Forschung Hamburg GmbH

    Hamburg, Germany

  • Medamed- Studienambulanz

    Leipzig, Germany

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.